ONDS Stock Rises Following Acquisition Of Israel-Based Sentry CS
Ondas expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.
Stocktwits·20d ago
Time to fade momentum trade, Jefferies says
Investing.com -- The momentum factor weakened in December, but more downside can be expected in the first quarter, according to a Jefferies strategist.
investing.com·11mo ago
Aquestive Therapeutics Pushes Retail Sentiment Into ‘Extremely Bullish’ Zone On OAS Drug Trial Success
This study marks the final supportive adult trial in the Anaphylm development program ahead of discussions with the U.S. FDA.